Acta Neurobiologiae Experimentalis · 2007 · 25 citations · 20 references
Life SciencesNeurosciencePharmacologyApoptosisMolecular NeuroscienceNeuropharmacologyApoptosis RegulationApoptotic SignalingIntrinsic Apoptotic PathwayNeuronal Cell DeathNeuroprotectionStatus EpilepticusAnti-apoptotic BalanceAnti-apoptotic ProteinsApoptotic Neuronal DeathNeuronal DysfunctionPreconditioning TreatmentsPro-apoptotic Bcl-2 ProteinsRodent EpilepsySeizures
Status epilepticus (SE) is a grave condition in which the brain undergoes lasting seizures which can lead to neuronal loss. Our previous study suggested that preconditioning with erythropoietin (Epo) suppressed neuronal apoptosis in hippocampus of rats following SE in vivo by inhibiting caspase-3. In this study, we investigated the mechanisms by which Epo preconditioning may exert its anti-apoptotic effects using a lithium-pilocarpine induced SE model in rats. The effects of Epo on neuronal cell death were evaluated using terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL), and the role of the Bcl-2 protein family, which have been shown to be anti- (Bcl-2, Bcl-w) or pro- (Bid, Bim) apoptotic, was examined with immunofluorescence. We found Epo preconditioning decreased the total number of TUNEL, Bim and Bid positive cells, but increased the total number of Bcl-w and Bcl-2 positive cells. These results suggest that systemic Epo pretreatment protects neurons in an acute phase of SE and may result in further suppression of neuronal apoptosis in hippocampus by regulating the balance between pro- and anti-apoptotic Bcl-2 family proteins.
20
BID: a novel BH3 domain-only death agonist.
Kai Wang, Xiaoming Yin, Debra T. Chao et al. · Genes & Development · 1996 · 962 citations · Full text
Actin cleavage by CPP-32/apopain during the development of apoptosis
Tetsuo Mashima, Mikihiko Naito, Kohji Noguchi et al. · Oncogene · 1997 · 253 citations